. Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease. Neuropharmacology. 2017 Oct;125:50-63. Epub 2017 Jul 12 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.